BMO Capital Downgrades Tornier (TRNX) to Market Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech selloff pulls Wall Street to two-week lows as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Tech selloff pulls Wall Street to two-week lows as bond yields climb
- Francisco Partners to acquire Weave Communications for $650M
Piper Jaffray Downgrades Tornier (TRNX) to Neutral Amid Merger
November 3, 2014 6:34 AM ESTPiper Jaffray downgraded Tornier (NASDAQ: TRNX) from Overweight to Neutral with a price target of $30.00 (from $26.00) following merger with Wright Medical.
For an analyst ratings summary and ratings history on Tornier click here. For more ratings news on Tornier click here.
Shares of Tornier closed at $27.95 yesterday.
... More